Mus vs Puerto Rico: Treatment success rate for patients treated for MDR-TB
Mus
100.0%
in 2022
Puerto Rico
100.0%
in 2020
Mus rank
1st
Puerto Rico rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Mus
- Puerto Rico
How they compare
Mus currently reports 100.0% against 100.0% in Puerto Rico, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2006 it was Mus ahead.
Mus ranks 1st and Puerto Rico ranks 1st of 1 regions.
Across the 2 decades both report, Mus averaged higher in 1 and Puerto Rico in 1.
Head to head by decade
| Decade | Mus | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.3% | 33.3% | 50.0% | Mus |
| 2010s | 83.3% | 89.0% | 5.7% | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Mus or Puerto Rico?
- Mus, at 100.0% against 100.0% in Puerto Rico as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Mus and Puerto Rico?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Puerto Rico?
- 6 years are reported by both, from 2006 to 2019.
- How do Mus and Puerto Rico rank globally for treatment success rate for patients treated for mdr-tb?
- Mus ranks 1st and Puerto Rico ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.